Furthermore, we also observed the expression of GM-CSF receptors in tumor cells of specimens from CRC patients (Fig. 1b), indicating a direct responsiveness of colon cancer cells to GM-CSF. This evidence concerns the gene CSF2 and colorectal carcinoma.